Simplex Trading, LLC Oncternal Therapeutics, Inc. Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.63 - $1.3 $309 - $639	-492 Reduced 6.47%	7,111 $5,000
Q4 2022 Feb 02, 2023	BUY	$0.86 - $22.2 $1,965 - $50,727	2,285 Added 42.97%	7,603 $7,000
Q3 2022 Nov 04, 2022	SELL	$0.83 - $17.8 $46,609 - $999,576	-56,156 Reduced 91.35%	5,318 $4,000
Q2 2022 Aug 03, 2022	BUY	$0.7 - $1.56 $17,802 - $39,673	25,432 Added 70.56%	61,474 $68,000
Q1 2022 May 02, 2022	BUY	$1.37 - $2.43 $35,807 - $63,512	26,137 Added 263.88%	36,042 $50,000
Q4 2021 Feb 23, 2022	SELL	$2.27 - $4.39 $85,726 - $165,788	-37,765 Reduced 79.22%	9,905 $22,000
Q2 2021 Aug 12, 2021	BUY	$4.75 - $9.39 $44,189 - $87,355	9,303 Added 24.25%	47,670 $226,000
Q1 2021 Apr 26, 2021	BUY	$4.59 - $9.04 $160,787 - $316,671	35,030 Added 1049.75%	38,367 $319,000
Q4 2020 Feb 02, 2021	BUY	$1.51 - $6.3 $5,038 - $21,023	3,337 New	3,337 $16,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.